Moreover, plasma HGF strongly associated with Model for End-stage Liver Disease (MELD) score, a validated measure of liver disease severity, in HCC patients undergoing liver transplantation (Spearman rho = 0.54, p < 0.0001). Here, HGF is linked to End Stage Liver Disease.